| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Intravenous Immunolobulin (IV Ig) Treatment of Demyelinating Polyneuropathy in Patient with Systemic Lupus Erythematosus (SLE) : A Case Report and Review of the Literatures. | Siraphop Suwannaroj Ratanavadee Nanagara Valee Harisdandkul |
1998 | ||||
| 2. | Treatment of Gout in General Practice | Siraphop Suwannaroj Ratanavadee Nanagara |
1998 | ||||
| 3. | Systemic lupus erythematosus and Castleman's disease. | Suwannaroj, S. | 1999 | ||||
| 4. | Atypical morphological characteristics and surface antigen expression of Burkholderia pseudomallei in naturally infected human synovial tissues. | Nanagara, R Vipulakorn, K Suwannaroj, S Schumacher, HR |
2000 | ||||
| 5. | 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A | Suwannaroj, S. | 2001 | ||||
| 6. | Antioxidants suppress mortality in the female NZB × NZW F1 mouse model of systemic lupus erythematosus (SLE) | Suwannaroj, S. | 2001 | ||||
| 7. | Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE). | S Suwannaroj A Lagoo D Keisler RW McMurray |
2001 | ||||
| 8. | Differential effects of sex steroids on T and B cells: Modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels | McMurray, RW Suwannaroj, S Ndebele, K Jenkins, JK |
2001 | ||||
| 9. | Long term treatment outcome of Salmonella septic arthritis. | R Nanagara S Suwannaroj A Mahakkanukrauh HR Schumacher |
2001 | ||||
| 10. | Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus | Suwannaroj, S. Mootsikapun, P. Vipulakorn, K. Nanagara, R. |
2001 | ||||
| 11. | Suppression of renal disease and mortality in the female NZB×NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid | Suwannaroj, S. | 2001 | ||||
| 12. | Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. | S Suwannaroj A Lagoo RW McMurray |
2001 | ||||
| 13. | The association of HLA and systemic sclerosis (SSc) in the Northeastern Thais - A preliminary study in 60 patients | S Suwannaroj A Mahakkanukrah C Leelayuwat A Romphruk C Puapairoj R Nanagara |
2001 | ||||
| 14. | Quinolones and Salmonella septic arthritis. | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2002 | ||||
| 15. | Tuberculous pyomyositis. | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2003 | ||||
| 16. | Interesting case anaphylaxis after intra-articular steroid injection in out patient department : review literature | Chingching Foocharoen Siraphop Suwannaroj |
2004 | ||||
| 17. | Systemic sclerosis (SSC) in the northeastern Thais: A clinical data in 506 patients | S Suwannaroj A Mahakkanukrauh R Nanagara |
2004 | ||||
| 18. | D-dimer and pulmonary arterial hypertension in systemic sclerosis | Kiatchoosakun, S Ungkasekvinai, W Wonvipaporn, C Tatsanavivat, P Foocharoen, C Suwannaroj, S Nanagara, R |
2007 | ||||
| 19. | Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. | Foocharoen, C. Nanagara, R. Salang, L. Suwannaroj, S. Mahakkanukrauh, A. |
2009 | ||||
| 20. | CLINICAL FEATURES OF TUBERCULOUS SEPTIC ARTHRITIS IN KHON KAEN, THAILAND A 10-YEAR RETROSPECTIVE STUDY | Foocharoen, C Nanagara, R Foocharoen, T Mootsikapun, P Suwannaroj, S Mahakkanukrauh, A |
2010 | ||||
| 21. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand | Foocharoen, C Nanagara, R Suwannaroj, S Mahakkanukrauh, A |
2011 | ||||
| 22. | Erratum: Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients (Clin Rheumatol (2011) 30 (1263) DOI 10.1007/s10067-011-1744-z) | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2011 | ||||
| 23. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand | Foocharoen, C. Nanagara, R. Kiatchoosakun, S. Suwannaroj, S. Mahakkanukrauh, A. |
2011 | ||||
| 24. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. | Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2011 | ||||
| 25. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment | Foocharoen, C Nanagara, R Suwannaroj, S Mahakkanukrauh, A |
2011 | ||||
| 26. | Development of Quality Indicators of Dispensing Process for Hospital Pharmacists in Rheumatoid Arthritis Patients | Ratchanok Boondee Pattarin Kittiboonyakun Siraphop Suwannaroj Phayom Sookaneknun |
2012 | ||||
| 27. | INCIDENCE RATE AND CAUSES OF INFECTION IN THAI SSc PATIENTS | C. Foocharoen Y. Siriphanon A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 | ||||
| 28. | Incidence rate and causes of infection in Thai systemic sclerosis patients | Foocharoen, C Siriphannon, Y Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 | ||||
| 29. | Pattern of skin thickness progression and clinical correlation in thai scleroderma patients | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 | ||||
| 30. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. | Kunyakham, W. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 | ||||
| 31. | PROGNOSTIC FACTORS OF MORTALITY AND 2-YEAR SURVIVAL ANALYSIS OF SSc WITH PULMONARY ARTERIAL HYPERTENSION IN THAILAND | C. Foocharoen R. Nanagara S. Kiatchoosakun S. Suwannaroj A. Mahakkanukrauh |
2012 | ||||
| 32. | SPONTANEOUS SKIN REGRESSION AND PREDICTORS OF SKIN REGRESSION IN THAI SCLERODERMA PATIENTS | C. Foocharoen A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 | ||||
| 33. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. | Chingching Foocharoen Yupa Thavornpitak Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 | ||||
| 34. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database | Mahakkanukrauh, A. Thavornpitak, Y. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2013 | ||||
| 35. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. | Netwijitpan, S. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 | ||||
| 36. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients | Patipat Kitchongcharoenying Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 | ||||
| 37. | ASYMPTOMATIC CARDIAC INVOLVEMENT IN THAI SYSTEMIC SCLEROSIS: PREVALENCE AND CLINICAL CORRELATION | C. Foocharoen B. Pussadhamma A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2014 | ||||
| 38. | Clinical characteristics and mortality in systemic sclerosis: A comparison between early- and late-referred diseases | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 | ||||
| 39. | Incidence of Pulmonary Hypertension in Patients With Systemic Sclerosis and No Pulmonary Symptoms: Is Annual Echocardiographic Screening Necessary? | Foocharoen, C Mahakkanukrauh, A Pussadhamma, B Netwijitpan, S Suwannaroj, S Nanagara, R |
2014 | ||||
| 40. | Prevalence and causes of loss to follow-up among patients with systemic sclerosis | Foocharoen, C Yenrom, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 | ||||
| 41. | Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). | Chingching Foocharoen Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2015 | ||||
| 42. | Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2015 | ||||
| 43. | Inter-and intra-observer reliability of modified rodnan skin score assessment in Thai systemic sclerosis patients: A validation for multicenter scleroderma cohort study | Foocharoen, C. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Towiwat, P. Nanagara, R. |
2015 | ||||
| 44. | Asymptomatic cardiac involvement in Thai systemic sclerosis: Prevalence and clinical correlations withn non-cardiac manifestations (preliminary report) | Foocharoen, C. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 | ||||
| 45. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma | Foocharoen, C Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2016 | ||||
| 46. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I | Chingching Foocharoen Prangsuporn Suwannachat Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2016 | ||||
| 47. | Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma. | Patcharawan Suebmee Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Daris Theerakulpisut Ratanavadee Nanagara |
2016 | ||||
| 48. | Self-assessment of skin tightness severity by scleroderma patients | Daungkum, K Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B Nanagara, R |
2016 | ||||
| 49. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Hanvivadhanakul, P. Mahakkanukrauh, A. Suwannaroj, S. Koolvisoot, A. Nanagara, R. Nuntirooj, K. |
2017 | ||||
| 50. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial. | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2017 | ||||
| 51. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2017 | ||||
| 52. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis. | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Limpawattana, P. Nanagara, R. |
2018 | ||||
| 53. | Disease modifying anti-rheumatic drugs [dmards] used and treatment outcome of rheumatoid arthritis in rheumatology clinic, Srinagarind Hospital | Nanagara, R. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2018 | ||||
| 54. | Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients | Siriphannon, Y. Foocharoen, C. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2018 | ||||
| 55. | Pulmonary manifestation in systemic sclerosis in Srinagarind Hospital | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. Tumsatan, P. |
2018 | ||||
| 56. | The effect of 4 milligrams intravenous zoledronic acid once yearly on bone mineral density and biochemical bone markers in systemic sclerosis patients with osteoporosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Pongchaiyakul, C. Nanagara, R. |
2018 | ||||
| 57. | The effects of bosentan on the survival, safety, and tolerability in pulmonary hypertension as related to diffuse cutaneous systemic sclerosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Kiatchoosakun, S. Wantha, O. Nanagara, R. |
2018 | ||||
| 58. | Ways to improve scores in objective-base long case examination for 6 th -year medical students in the internal medicine rotation | Suwannaroj, S. Sawanyawisuth, K. Panitchote, A. |
2018 | ||||
| 59. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Pussadhamma, B. Chaosuwannakit, N. |
2019 | ||||
| 60. | Effect of season on clinical outcomes of Thai systemic sclerosis: analysis of the Thai national healthcare database. | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2019 | ||||
| 61. | PREVALENCE OF PERIPHERAL EOSINOPHILIA AND CLINICAL ASSOCIATIONS IN THAI SYSTEMIC SCLEROSIS PATIENTS | Chingching Foocharoen Patnarin Kongkulkiat Ajanee Mahakkanukrauh Pewpan Maleewong Intapan Wanchai Maleewong Amonrat Jumnainsong Nattiya Teawtrakul Siraphop Suwannaroj Ratanavadee Nanagara |
2019 | ||||
| 62. | Scleroderma renal crisis after steroid therapy in interstitial lung disease, as initial presentation in a limited cutaneous scleroderma patient: Case report | Tonsawan, P. Chan-On, C. Suwannaroj, S. |
2019 | ||||
| 63. | TUBERCULIN SKIN TEST FOR DETECTION OF TUBERCULOSIS IN SYSTEMIC SCLEROSIS | Apichat So-Ngern Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2019 | ||||
| 64. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis. | Krikeerati, T Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2020 | ||||
| 65. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study | Chingching Foocharoen Udomlack Peansukwech Ajanee Mahakkanukrauh Siraphop Suwannaroj Patnarin Pongkulkiat Penpiriya Khamphiw Ratanavadee Nanagara |
2020 | ||||
| 66. | Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study | Burabha Pussadhamma Thapanee Tipparot Naruemol Chaosuwannakit Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2020 | ||||
| 67. | Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2020 | ||||
| 68. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study | Chingching Foocharoen Kitti Chunlertrith Pisaln Mairiang Ajanee Mahakkanukrauh Siraphop Suwannaroj Suwassa Namvijit Orathai Wantha Ratanavadee Nanagara |
2020 | ||||
| 69. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database. | Chingching Foocharoen Udomlack Peansukwech Patnarin Pongkulkiat Ajanee Mahakkanukrauh Siraphop Suwannaroj |
2021 | ||||
| 70. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis | Thanachit Krikeerati Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 | ||||
| 71. | Clinical Differences in Lupus Nephritis in Thai Patients with Systemic Lupus Erythematosus with Positive vs. Negative Anti-dsDNA Antibody | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 | ||||
| 72. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study) | Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 | ||||
| 73. | Incidence of anti-topoisomerase I antibody seroconversion and clinical association in systemic sclerosis | Srikamud, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 | ||||
| 74. | Incidence Rate, Causes and Predictors of Opportunistic Infection during High-Dose Steroid with and without Immunosuppressant Therapy in Thais with Systemic Lupus Erythematosus | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 | ||||
| 75. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2021 | ||||
| 76. | Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis | Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 | ||||
| 77. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. | Salang, L. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2021 | ||||
| 78. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis | Wiriya Chuealee Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Chatlert Pongchaiyakul Ratanavadee Nanagara |
2021 | ||||
| 79. | Prevalence, Classification, and Outcomes of Pulmonary Hypertension in Thai Systemic Sclerosis | Pussadhamma, B. Tumsatan, P. Foocharoen, C. Suwannaroj, S. Nanagara, R. Mahakkanukrauh, A. |
2021 | ||||
| 80. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients | Paolee, Y Foocharoen, C Charoensri, S Mayxay, M Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2021 | ||||
| 81. | Development and validation of machine learning for early mortality in systemic sclerosis. | Foocharoen, C. Thinkhamrop, W. Chaichaya, N. Mahakkanukrauh, A. Suwannaroj, S. Thinkhamrop, B. |
2022 | ||||
| 82. | Management pitfalls and prevalence of lost to follow-up due to unpredicted death in systemic sclerosis | Pongkulkiat, P. Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 | ||||
| 83. | Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis | Laovirojjanakul, W Yospaiboon, Y Anutarapongpan, O Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2022 | ||||
| 84. | Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis. | Sangaroon, A. Foocharoen, C. Theerakulpisut, D. Srichompoo, K. Mahakkanukrauh, A. Suwannaroj, S. Seerasaporn, P. Pongchaiyakul, C. |
2022 | ||||
| 85. | Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis | Thepwiwatjit, S Charoensri, S Sirithanaphol, W Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 | ||||
| 86. | Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis | Rompsaithong, U Sirithanaphol, W Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 | ||||
| 87. | Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients | Foocharoen, C Mahakkanukrauh, A Maleewong, P Maleewong, W Jumnainsong, A Pongkulkiat, P Teawtrakul, N Suwannaroj, S Nanagara, R |
2022 | ||||
| 88. | Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis | Pongkulkiat, P Thinkhamrop, B Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 | ||||
| 89. | Skin thickness affects the result of tuberculin skin test in systemic sclerosis. | So-ngern, A. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 | ||||
| 90. | Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients | Wantha, O Mahakkanukrauh, A Tuydaung, K Donsrichan, W Yingyaun, K Kaewmeun, S Suwannaroj, S Foocharoen, C |
2023 | ||||
| 91. | Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients | Foocharoen, C Kingkaew, P Teerawattananon, Y Mahakkanukrauh, A Suwannaroj, S Manasirisuk, W Chaiyarit, J Sangchan, A |
2023 | ||||
| 92. | Effects of Low-dose Aspirin on Serum Uric Acid among Asymptomatic Hyperuricemia Patients with Cardiovascular Risk Factors | Silisay, V. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2023 | ||||
| 93. | Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study. | Sriwong, W.T. Srisangwarn, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 | ||||
| 94. | Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health | Foocharoen, T Onchan, T Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 | ||||
| 95. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health. | Foocharoen, C Ngamjarus, C Pattanittum, P Suwannaroj, S Pongkulkiat, P Onchan, T Wattanasukchai, L Chaiyarit, J Mahakkanukrauh, A |
2023 | ||||
| 96. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017–2020: a database from the Ministry of Public Health | Foocharoen, C. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Wattanasukchai, L. Chaiyarit, J. Mahakkanukrauh, A. |
2023 | ||||
| 97. | Management review of scleroderma renal crisis: An update with practical pointers | Foocharoen, C Tonsawan, P Pongkulkiat, P Anutrakulchai, S Mahakkanukrauh, A Suwannaroj, S |
2023 | ||||
| 98. | Sleep quality and clinical association with sleep disturbance in systemic sclerosis | Wongthawa, N So-Gnern, A Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 | ||||
| 99. | Treatment Outcome of Ankylosing Spondylitis in Srinagarind Hospital | Uthaiphan, S. Foocharoen, C. Suwannaroj, S. Pongkulkiat, P. Mahakkanukrauh, A. |
2023 | ||||
| 100. | Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study. | Werakiat, J. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2024 | ||||
| 101. | Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis. | Onchan, T. Foocharoen, C. Pongkulkiat, P. Suwannaroj, S. Mahakkanukrauh, A. |
2024 | ||||
| 102. | Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody | Suwannamajo, R Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2024 | ||||
| 103. | Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients | Mulalin, K Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Onchan, T Kasa, S Foocharoen, C |
2024 | ||||
| 104. | Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up. | Mahakkanukrauh, A. Foocharoen, C. Chaosuwannakit, N. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Pussadhamma, B. |
2024 | ||||
| 105. | The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database. | Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2024 | ||||
| 106. | Case Report: Chalk-Like Synovial Fluid and Calcified Synovium in Systemic Sclerosis Overlapping With Rheumatoid Arthritis Stabilized by Rituximab. | Khounthep, A. Thummaroj, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 | ||||
| 107. | Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia | Hongkanjanapong, S Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2025 | ||||
| 108. | Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients | Rujirawinitchai, P. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. |
2025 | ||||
| 109. | Effects of a Self-Management Telehealth Program on Improving Strength and Hand Function in Systemic Sclerosis Patients: A Randomized Controlled Trial | Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Tuydaung, K. Methakanjanasak, N. Srichomphu, K. Kraipoj, J. Foocharoen, C. |
2025 | ||||
| 110. | Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon. | Namvijit, S. Foocharoen, C. Suwannaroj, S. Pongkulkait, P. Onchan, T. Mahakkanukrauh, A. |
2025 | ||||
| 111. | Efficacy of Cannabis Oil in Improving Subjective Sleep Quality in Systemic Sclerosis: A Prospective Placebo-Controlled Study | So-ngern, A. Sripanichkulchai, B. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kanokmedhakul, S. Foocharoen, C. |
2025 | ||||
| 112. | Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis. | Mahakkanukrauh, A. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 | ||||
| 113. | Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review | Senaveenin, N Mahakkanukrauh, A Foocharoen, C Suwannaroj, S Onchan, T Pongkulkiat, P |
2025 | ||||
| 114. | Prescription errors in patients with systemic sclerosis: Exploratory data analysis from scleroderma clinic | Namvijit, S. Mahakkanurauk, A. Suwannaroj, S. Pongkulkait, P. Onchan, T. Foocharoen, C. |
2025 | ||||
| 115. | Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset | Chaovanitkul, C. Onchan, T. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 | ||||
| 116. | Unraveling the relationship between disordered sleep and systemic sclerosis outcomes | So-Gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 | ||||
| 117. | Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire. | Ruangnopparut, R. Osiri, M. Suwannaroj, S. Mahakkanukrauh, A. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 | Count | 95 | 74 | 51 | 4 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Systemic lupus erythematosus and Castleman's disease | Suwannaroj, S. | 1999 |
Journal of Rheumatology 6 (26), pp. 1400-1403 |
||||||||
| 2. | 17-β-Estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A | Suwannaroj, S. | 2001 |
International Immunopharmacology 11 (1), pp. 1897-1911 |
||||||||
| 3. | Antioxidants suppress mortality in the female NZB × NZW F1 mouse model of systemic lupus erythematosus (SLE) | Suwannaroj, S. | 2001 |
Lupus 4 (10), pp. 258-265 |
||||||||
| 4. | Differential effects of sex steroids on T and B cells: Modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels | Suwannaroj, S. | 2001 |
Pathobiology 1 (69), pp. 44-58 |
||||||||
| 5. | Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus | Suwannaroj, S. Mootsikapun, P. Vipulakorn, K. Nanagara, R. |
2001 |
Journal of Clinical Rheumatology 2 (7), pp. 83-85 |
||||||||
| 6. | Suppression of renal disease and mortality in the female NZB×NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid | Suwannaroj, S. | 2001 |
Lupus 8 (10), pp. 562-567 |
||||||||
| 7. | Quinolones and Salmonella septic arthritis | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2002 |
Journal of the Medical Association of Thailand 9 (85), pp. 984-989 |
||||||||
| 8. | Tuberculous pyomyositis | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2003 |
Journal of the Medical Association of Thailand 5 (86), pp. 477-481 |
||||||||
| 9. | D-dimer and pulmonary arterial hypertension in systemic sclerosis | Kiatchoosakun, S. Ungkasekvinai, W. Tatsanavivat, P. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2007 |
Journal of the Medical Association of Thailand 10 (90), pp. 2024-2029 |
||||||||
| 10. | Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): A study at srinagarind hospital | Foocharoen, C. Nanagara, R. Salang, L. Suwannaroj, S. Mahakkanukrauh, A. |
2009 |
Journal of the Medical Association of Thailand 2 (92), pp. 167-174 |
||||||||
| 11. | Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: A 10-year retrospective study | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2010 |
Southeast Asian Journal of Tropical Medicine and Public Health 6 (41), pp. 1438-1446 |
||||||||
| 12. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2011 |
International Journal of Rheumatic Diseases 3 (14), pp. e14-e21 |
||||||||
| 13. | Erratum: Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients (Clin Rheumatol (2011) 30 (1263) DOI 10.1007/s10067-011-1744-z) | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2011 |
Clinical Rheumatology 9 (30), pp. 1263 |
||||||||
| 14. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand | Foocharoen, C. Nanagara, R. Kiatchoosakun, S. Suwannaroj, S. Mahakkanukrauh, A. |
2011 |
International Journal of Rheumatic Diseases 3 (14), pp. 282-289 |
||||||||
| 15. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2011 |
Clinical Rheumatology 9 (30), pp. 1235-1240 |
||||||||
| 16. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2011 |
International Journal of Rheumatic Diseases 4 (14), pp. 353-360 |
||||||||
| 17. | Incidence rate and causes of infection in Thai systemic sclerosis patients | Foocharoen, C. Siriphannon, Y. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 |
International Journal of Rheumatic Diseases 3 (15), pp. 277-283 |
||||||||
| 18. | Pattern of skin thickness progression and clinical correlation in thai scleroderma patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 |
International Journal of Rheumatic Diseases 5 (15), pp. e90-e95 |
||||||||
| 19. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients | Kunyakham, W. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 |
Asian Pacific Journal of Allergy and Immunology 2 (30), pp. 152-157 |
||||||||
| 20. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: Analysis from a nationwide Thailand healthcare database | Foocharoen, C. Thavornpitak, Y. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 |
International Journal of Rheumatic Diseases 1 (16), pp. 41-46 |
||||||||
| 21. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database | Mahakkanukrauh, A. Thavornpitak, Y. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2013 |
International Journal of Rheumatic Diseases 4 (16), pp. 387-391 |
||||||||
| 22. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis | Netwijitpan, S. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 |
Clinical Rheumatology 3 (32), pp. 361-367 |
||||||||
| 23. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 |
Asian Pacific Journal of Allergy and Immunology 4 (31), pp. 314-319 |
||||||||
| 24. | Clinical characteristics and mortality in systemic sclerosis: A comparison between early- and late-referred diseases | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2014 |
Journal of the Medical Association of Thailand 1 (97), pp. 28-35 |
||||||||
| 25. | Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: Is annual echocardiographic screening necessary? | Foocharoen, C. Mahakkanukrauh, A. Pussadhamma, B. Netwijitpan, S. Suwannaroj, S. Nanagara, R. |
2014 |
Journal of Clinical Rheumatology 5 (20), pp. 268-274 |
||||||||
| 26. | Prevalence and causes of loss to follow-up among patients with systemic sclerosis | Foocharoen, C. Yenrom, P. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2014 |
Journal of Clinical Rheumatology 8 (20), pp. 456 |
||||||||
| 27. | Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2015 |
Archives of Medical Science 6 (11), pp. 1255-1260 |
||||||||
| 28. | Inter-and intra-observer reliability of modified rodnan skin score assessment in Thai systemic sclerosis patients: A validation for multicenter scleroderma cohort study | Foocharoen, C. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Towiwat, P. Nanagara, R. |
2015 |
Journal of the Medical Association of Thailand 11 (98), pp. 1082-1088 |
||||||||
| 29. | Asymptomatic cardiac involvement in Thai systemic sclerosis: Prevalence and clinical correlations withn non-cardiac manifestations (preliminary report) | Foocharoen, C. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
Rheumatology (United Kingdom) 9 (54), pp. 1616-1621 |
||||||||
| 30. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
International Journal of Rheumatic Diseases 9 (19), pp. 913-923 |
||||||||
| 31. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
International Journal of Rheumatic Diseases 3 (19), pp. 312-320 |
||||||||
| 32. | Self-assessment of skin tightness severity by scleroderma patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
International Journal of Rheumatic Diseases 10 (19), pp. 989-995 |
||||||||
| 33. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Hanvivadhanakul, P. Mahakkanukrauh, A. Suwannaroj, S. Koolvisoot, A. Nanagara, R. Nuntirooj, K. |
2017 |
International Journal of Rheumatic Diseases 9 (20), pp. 1166-1184 |
||||||||
| 34. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: Randomized placebo-controlled trial | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2017 |
Rheumatology (United Kingdom) 2 (56), pp. 214-222 |
||||||||
| 35. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2017 |
Rheumatology (Oxford, England) 2 (56), pp. 214-222 |
||||||||
| 36. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2017 |
International Journal of Rheumatic Diseases 10 (20), pp. 1572-1581 |
||||||||
| 37. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Limpawattana, P. Nanagara, R. |
2018 |
Clinical and Experimental Rheumatology (36), pp. S76-S81 |
||||||||
| 38. | Disease modifying anti-rheumatic drugs [dmards] used and treatment outcome of rheumatoid arthritis in rheumatology clinic, Srinagarind Hospital | Nanagara, R. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S31-S39 |
||||||||
| 39. | Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients | Siriphannon, Y. Foocharoen, C. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S235-S243 |
||||||||
| 40. | Pulmonary manifestation in systemic sclerosis in Srinagarind Hospital | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. Tumsatan, P. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S213-S219 |
||||||||
| 41. | The effect of 4 milligrams intravenous zoledronic acid once yearly on bone mineral density and biochemical bone markers in systemic sclerosis patients with osteoporosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Pongchaiyakul, C. Nanagara, R. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S125-S130 |
||||||||
| 42. | The effects of bosentan on the survival, safety, and tolerability in pulmonary hypertension as related to diffuse cutaneous systemic sclerosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Kiatchoosakun, S. Wantha, O. Nanagara, R. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S51-S55 |
||||||||
| 43. | Ways to improve scores in objective-base long case examination for 6 <sup>th</sup> -year medical students in the internal medicine rotation | Suwannaroj, S. Sawanyawisuth, K. Panitchote, A. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S177-S181 |
||||||||
| 44. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Pussadhamma, B. Chaosuwannakit, N. |
2019 |
International Journal of Rheumatic Diseases 12 (22), pp. 2125-2133 |
||||||||
| 45. | Scleroderma renal crisis after steroid therapy in interstitial lung disease, as initial presentation in a limited cutaneous scleroderma patient: Case report | Tonsawan, P. Chan-On, C. Suwannaroj, S. |
2019 |
Journal of the Medical Association of Thailand 6 (102), pp. 724-728 |
||||||||
| 46. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2020 |
International Journal of Rheumatic Diseases 7 (23), pp. 945-957 |
||||||||
| 47. | Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study | Pussadhamma, B. Tipparot, T. Chaosuwannakit, N. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2020 |
International Journal of Rheumatology (2020), pp. |
||||||||
| 48. | Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2020 |
Modern Rheumatology 6 (30), pp. 1025-1032 |
||||||||
| 49. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2020 |
Scientific Reports 1 (10), pp. |
||||||||
| 50. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 51. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis | Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 |
Modern Rheumatology 3 (31), pp. 649-656 |
||||||||
| 52. | Clinical Differences in Lupus Nephritis in Thai Patients with Systemic Lupus Erythematosus with Positive vs. Negative Anti-dsDNA Antibody | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S43-S49 |
||||||||
| 53. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study) | Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 |
American Journal of the Medical Sciences 6 (362), pp. 576-583 |
||||||||
| 54. | Incidence of anti-topoisomerase I antibody seroconversion and clinical association in systemic sclerosis | Srikamud, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 |
Asia-Pacific Journal of Science and Technology 2 (26), pp. |
||||||||
| 55. | Incidence Rate, Causes and Predictors of Opportunistic Infection during High-Dose Steroid with and without Immunosuppressant Therapy in Thais with Systemic Lupus Erythematosus | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S50-S55 |
||||||||
| 56. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2021 |
Clinical Rheumatology 1 (40), pp. 205-211 |
||||||||
| 57. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis | Salang, L. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2021 |
Clinical Rheumatology 6 (40), pp. 2267-2275 |
||||||||
| 58. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Pongchaiyakul, C. Nanagara, R. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 59. | Prevalence, Classification, and Outcomes of Pulmonary Hypertension in Thai Systemic Sclerosis | Pussadhamma, B. Tumsatan, P. Foocharoen, C. Suwannaroj, S. Nanagara, R. Mahakkanukrauh, A. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S88-S96 |
||||||||
| 60. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients | Foocharoen, C. Charoensri, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 61. | Development and validation of machine learning for early mortality in systemic sclerosis | Foocharoen, C. Thinkhamrop, W. Chaichaya, N. Mahakkanukrauh, A. Suwannaroj, S. Thinkhamrop, B. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 62. | Management pitfalls and prevalence of lost to follow-up due to unpredicted death in systemic sclerosis | Pongkulkiat, P. Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
Asia-Pacific Journal of Science and Technology 5 (27), pp. |
||||||||
| 63. | Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis | Laovirojjanakul, W. Yospaiboon, Y. Anutarapongpan, O. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 |
Clinical Ophthalmology (16), pp. 3447-3455 |
||||||||
| 64. | Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis | Sangaroon, A. Foocharoen, C. Theerakulpisut, D. Srichompoo, K. Mahakkanukrauh, A. Suwannaroj, S. Seerasaporn, P. Pongchaiyakul, C. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 65. | Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis | Thepwiwatjit, S. Charoensri, S. Sirithanaphol, W. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
Journal of Scleroderma and Related Disorders (), pp. |
||||||||
| 66. | Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis | Rompsaithong, U. Sirithanaphol, W. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
Rheumatology (Oxford, England) 10 (61), pp. 4016-4023 |
||||||||
| 67. | Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients | Foocharoen, C. Mahakkanukrauh, A. Maleewong, W. Jumnainsong, A. Teawtrakul, N. Suwannaroj, S. Nanagara, R. |
2022 |
American Journal of the Medical Sciences 6 (363), pp. 519-525 |
||||||||
| 68. | Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis | Pongkulkiat, P. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
BMC Rheumatology 1 (6), pp. |
||||||||
| 69. | Skin thickness affects the result of tuberculin skin test in systemic sclerosis | So-ngern, A. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 |
BMC Rheumatology 1 (6), pp. |
||||||||
| 70. | Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients | Wantha, O. Mahakkanukrauh, A. Tuydaung, K. Donsrichan, W. Yingyaun, K. Kaewmeun, S. Suwannaroj, S. Foocharoen, C. |
2023 |
International Journal of Rheumatic Diseases 4 (26), pp. 751-758 |
||||||||
| 71. | Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients | Foocharoen, C. Kingkaew, P. Teerawattananon, Y. Mahakkanukrauh, A. Suwannaroj, S. Manasirisuk, W. Chaiyarit, J. Sangchan, A. |
2023 |
International Journal of Rheumatic Diseases 10 (26), pp. 2037-2046 |
||||||||
| 72. | Effects of Low-dose Aspirin on Serum Uric Acid among Asymptomatic Hyperuricemia Patients with Cardiovascular Risk Factors | Silisay, V. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2023 |
Journal of the Medical Association of Thailand 4 (104), pp. S82-S88 |
||||||||
| 73. | Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study | Sriwong, W.T. Srisangwarn, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 |
Clinical Rheumatology 1 (42), pp. 117-124 |
||||||||
| 74. | Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health | Foocharoen, T. Onchan, T. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 |
Open Access Rheumatology: Research and Reviews (15), pp. 213-222 |
||||||||
| 75. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017–2020: a database from the Ministry of Public Health | Foocharoen, C. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Wattanasukchai, L. Chaiyarit, J. Mahakkanukrauh, A. |
2023 |
Clinical Rheumatology 7 (42), pp. 1767-1774 |
||||||||
| 76. | Management review of scleroderma renal crisis: An update with practical pointers | Foocharoen, C. Tonsawan, P. Pongkulkiat, P. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. |
2023 |
Modern rheumatology 1 (33), pp. 12-20 |
||||||||
| 77. | Sleep quality and clinical association with sleep disturbance in systemic sclerosis | Wongthawa, N. So-gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 |
BMC Rheumatology 1 (7), pp. |
||||||||
| 78. | Treatment Outcome of Ankylosing Spondylitis in Srinagarind Hospital | Uthaiphan, S. Foocharoen, C. Suwannaroj, S. Pongkulkiat, P. Mahakkanukrauh, A. |
2023 |
Journal of the Medical Association of Thailand 4 (104), pp. S89-S93 |
||||||||
| 79. | Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study | Werakiat, J. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2024 |
Rheumatology and Immunology Research 2 (5), pp. 107-116 |
||||||||
| 80. | Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis | Onchan, T. Foocharoen, C. Pongkulkiat, P. Suwannaroj, S. Mahakkanukrauh, A. |
2024 |
Scientific Reports 1 (14), pp. |
||||||||
| 81. | Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody | Suwannamajo, R. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2024 |
Clinical, Cosmetic and Investigational Dermatology (17), pp. 301-309 |
||||||||
| 82. | Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients | Mulalin, K. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kasa, S. Foocharoen, C. |
2024 |
Scientific Reports 1 (14), pp. |
||||||||
| 83. | Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up | Mahakkanukrauh, A. Foocharoen, C. Chaosuwannakit, N. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Pussadhamma, B. |
2024 |
Rheumatology and Immunology Research 2 (5), pp. 117-125 |
||||||||
| 84. | The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database | Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2024 |
Scientific Reports 1 (14), pp. |
||||||||
| 85. | Case Report: Chalk-Like Synovial Fluid and Calcified Synovium in Systemic Sclerosis Overlapping With Rheumatoid Arthritis Stabilized by Rituximab | Khounthep, A. Thummaroj, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 |
International Journal of Rheumatic Diseases 7 (28), pp. |
||||||||
| 86. | Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia | Hongkanjanapong, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 |
American Journal of the Medical Sciences 1 (369), pp. 35-43 |
||||||||
| 87. | Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients | Rujirawinitchai, P. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. |
2025 |
Journal of Clinical Medicine 7 (14), pp. |
||||||||
| 88. | Effects of a Self-Management Telehealth Program on Improving Strength and Hand Function in Systemic Sclerosis Patients: A Randomized Controlled Trial | Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Tuydaung, K. Methakanjanasak, N. Srichomphu, K. Kraipoj, J. Foocharoen, C. |
2025 |
Life 7 (15), pp. |
||||||||
| 89. | Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon | Namvijit, S. Foocharoen, C. Suwannaroj, S. Pongkulkait, P. Onchan, T. Mahakkanukrauh, A. |
2025 |
Rheumatology and Immunology Research 1 (6), pp. 52-58 |
||||||||
| 90. | Efficacy of Cannabis Oil in Improving Subjective Sleep Quality in Systemic Sclerosis: A Prospective Placebo-Controlled Study | So-ngern, A. Sripanichkulchai, B. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kanokmedhakul, S. Foocharoen, C. |
2025 |
Life 5 (15), pp. |
||||||||
| 91. | Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis | Mahakkanukrauh, A. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 |
Annals of Medicine 1 (57), pp. |
||||||||
| 92. | Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review | Senaveenin, N. Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Onchan, T. Pongkulkiat, P. |
2025 |
Scientific Reports 1 (15), pp. |
||||||||
| 93. | Prescription errors in patients with systemic sclerosis: Exploratory data analysis from scleroderma clinic | Namvijit, S. Mahakkanurauk, A. Suwannaroj, S. Pongkulkait, P. Onchan, T. Foocharoen, C. |
2025 |
Asia Pacific Journal of Science and Technology 2 (30), pp. |
||||||||
| 94. | Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset | Chaovanitkul, C. Onchan, T. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 |
Life 7 (15), pp. |
||||||||
| 95. | Unraveling the relationship between disordered sleep and systemic sclerosis outcomes | So-Gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 |
Current Opinion in Rheumatology (), pp. |
||||||||
| 96. | Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire | Ruangnopparut, R. Osiri, M. Suwannaroj, S. Mahakkanukrauh, A. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 |
Clinical Rheumatology 8 (44), pp. 3235-3243 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Systemic lupus erythematosus and Castleman's disease. | Suwannaroj, S Elkins, SL McMurray, RW |
1999 |
The Journal of rheumatology 6 (26), pp. 1400-3 |
|
| 2. | Atypical morphological characteristics and surface antigen expression of Burkholderia pseudomallei in naturally infected human synovial tissues. | Nanagara, R Vipulakorn, K Suwannaroj, S Schumacher, HR |
2000 |
Modern rheumatology / the Japan Rheumatism Association 3 (10), pp. 129-36 |
|
| 3. | Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. | McMurray, RW Suwannaroj, S Ndebele, K Jenkins, JK |
2001 |
Pathobiology : journal of immunopathology, molecular and cellular biology 1 (69), pp. 44-58 |
|
| 4. | Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE). | Suwannaroj, S Lagoo, A Keisler, D McMurray, RW |
2001 |
Lupus 4 (10), pp. 258-65 |
|
| 5. | Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. | Suwannaroj, S Lagoo, A McMurray, RW |
2001 |
Lupus 8 (10), pp. 562-7 |
|
| 6. | 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. | Jenkins, JK Suwannaroj, S Elbourne, KB Ndebele, K McMurray, RW |
2001 |
International immunopharmacology 11 (1), pp. 1897-911 |
|
| 7. | Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus. | Suwannaroj, S Mootsikapun, P Vipulakorn, K Nanagara, R |
2001 |
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2 (7), pp. 83-5 |
|
| 8. | Quinolones and Salmonella septic arthritis. | Mootsikapun, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2002 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 9 (85), pp. 984-9 |
|
| 9. | Tuberculous pyomyositis. | Mootsikapun, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2003 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 5 (86), pp. 477-81 |
|
| 10. | D-dimer and pulmonary arterial hypertension in systemic sclerosis. | Kiatchoosakun, S Ungkasekvinai, W Wonvipaporn, C Tatsanavivat, P Foocharoen, C Suwannaroj, S Nanagara, R |
2007 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 10 (90), pp. 2024-9 |
|
| 11. | Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. | Foocharoen, C Nanagara, R Salang, L Suwannaroj, S Mahakkanukrauh, A |
2009 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2 (92), pp. 167-74 |
|
| 12. | Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: a 10-year retrospective study. | Foocharoen, C Nanagara, R Foocharoen, T Mootsikapun, P Suwannaroj, S Mahakkanukrauh, A |
2010 |
The Southeast Asian journal of tropical medicine and public health 6 (41), pp. 1438-46 |
|
| 13. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment. | Foocharoen, C Nanagara, R Suwannaroj, S Mahakkanukrauh, A |
2011 |
International journal of rheumatic diseases 4 (14), pp. 353-60 |
|
| 14. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2011 |
Clinical rheumatology 9 (30), pp. 1235-40 |
|
| 15. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand. | Foocharoen, C Nanagara, R Suwannaroj, S Mahakkanukrauh, A |
2011 |
International journal of rheumatic diseases 3 (14), pp. e14-21 |
|
| 16. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. | Foocharoen, C Nanagara, R Kiatchoosakun, S Suwannaroj, S Mahakkanukrauh, A |
2011 |
International journal of rheumatic diseases 3 (14), pp. 282-9 |
|
| 17. | Incidence rate and causes of infection in Thai systemic sclerosis patients. | Foocharoen, C Siriphannon, Y Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 |
International journal of rheumatic diseases 3 (15), pp. 277-83 |
|
| 18. | Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients. | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 |
International journal of rheumatic diseases 5 (15), pp. e90-5 |
|
| 19. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. | Kunyakham, W Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 |
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2 (30), pp. 152-7 |
|
| 20. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. | Kitchongcharoenying, P Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 |
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 4 (31), pp. 314-9 |
|
| 21. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. | Netwijitpan, S Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 |
Clinical rheumatology 3 (32), pp. 361-7 |
|
| 22. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. | Foocharoen, C Thavornpitak, Y Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 |
International journal of rheumatic diseases 1 (16), pp. 41-6 |
|
| 23. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: analysis from the nationwide hospital database. | Mahakkanukrauh, A Thavornpitak, Y Foocharoen, C Suwannaroj, S Nanagara, R |
2013 |
International journal of rheumatic diseases 4 (16), pp. 387-91 |
|
| 24. | Prevalence and causes of loss to follow-up among patients with systemic sclerosis. | Foocharoen, C Yenrom, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 |
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 8 (20), pp. 456 |
|
| 25. | Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary? | Foocharoen, C Mahakkanukrauh, A Pussadhamma, B Netwijitpan, S Suwannaroj, S Nanagara, R |
2014 |
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 5 (20), pp. 268-74 |
|
| 26. | Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases. | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1 (97), pp. 28-35 |
|
| 27. | Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). | Foocharoen, C Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2015 |
Rheumatology (Oxford, England) 9 (54), pp. 1616-21 |
|
| 28. | Self-assessment of skin tightness severity by scleroderma patients. | Daungkum, K Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B Nanagara, R |
2016 |
International journal of rheumatic diseases 10 (19), pp. 989-995 |
|
| 29. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. | Foocharoen, C Suwannachat, P Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R , , , , , , , , |
2016 |
International journal of rheumatic diseases 3 (19), pp. 312-20 |
|
| 30. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma. | Foocharoen, C Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2016 |
International journal of rheumatic diseases 9 (19), pp. 913-923 |
|
| 31. | Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma. | Suebmee, P Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Theerakulpisut, D Nanagara, R |
2016 |
The American journal of the medical sciences 2 (352), pp. 166-71 |
|
| 32. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. | Foocharoen, C Watcharenwong, P Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2017 |
International journal of rheumatic diseases 10 (20), pp. 1572-1581 |
|
| 33. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial. | Foocharoen, C Chunlertrith, K Mairiang, P Mahakkanukrauh, A Suwannaroj, S Namvijit, S Wantha, O Nanagara, R |
2017 |
Rheumatology (Oxford, England) 2 (56), pp. 214-222 |
|
| 34. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. | Louthrenoo, W Kasitanon, N Katchamart, W Aiewruengsurat, D Chevaisrakul, P Chiowchanwisawakit, P Dechanuwong, P Hanvivadhanakul, P Mahakkanukrauh, A Manavathongchai, S Muangchan, C Narongroeknawin, P Phumethum, V Siripaitoon, B Suesuwan, A Suwannaroj, S Uea-Areewongsa, P Ukritchon, S Asavatanabodee, P Koolvisoot, A Nanagara, R Totemchokchyakarn, K Nuntirooj, K Kitumnuaypong, T |
2017 |
International journal of rheumatic diseases 9 (20), pp. 1166-1184 |
|
| 35. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis. | Apipattarakul, R Foocharoen, C Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Limpawattana, P Nanagara, R |
2018 |
Clinical and experimental rheumatology 4 (36), pp. 76-81 |
|
| 36. | Effect of season on clinical outcomes of Thai systemic sclerosis: analysis of the Thai national healthcare database. | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2019 |
Modern rheumatology (), pp. 1-19 |
|
| 37. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study. | Tipparot, T Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R Pussadhamma, B Chaosuwannakit, N |
2019 |
International journal of rheumatic diseases 12 (22), pp. 2125-2133 |
|
| 38. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. | Foocharoen, C Chunlertrith, K Mairiang, P Mahakkanukrauh, A Suwannaroj, S Namvijit, S Wantha, O Nanagara, R |
2020 |
Scientific reports 1 (10), pp. 769 |
|
| 39. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis. | Krikeerati, T Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2020 |
Modern rheumatology (), pp. 1-20 |
|
| 40. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. | Foocharoen, C Peansukwech, U Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Khamphiw, P Nanagara, R |
2020 |
International journal of rheumatic diseases 7 (23), pp. 945-957 |
|
| 41. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study). | Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 |
The American journal of the medical sciences 6 (362), pp. 570-577 |
|
| 42. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease. | Arunsurat, I Mahakkanukrauh, A Foocharoen, C Suwannaroj, S Nanagara, R , |
2021 |
Clinical rheumatology 1 (40), pp. 205-211 |
|
| 43. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database. | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2021 |
Scientific reports 1 (11), pp. 7983 |
|
| 44. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis. | Chuealee, W Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Pongchaiyakul, C Nanagara, R |
2021 |
Scientific reports 1 (11), pp. 9424 |
|
| 45. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. | Jutiviboonsuk, A Salang, L Eamudomkarn, N Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2021 |
Clinical rheumatology 6 (40), pp. 2267-2275 |
|
| 46. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients. | Paolee, Y Foocharoen, C Charoensri, S Mayxay, M Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2021 |
Scientific reports 1 (11), pp. 14902 |
|
| 47. | Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis. | Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 |
Archives of medical science : AMS 6 (17), pp. 1696-1705 |
|
| 48. | Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis. | Sangaroon, A Foocharoen, C Theerakulpisut, D Srichompoo, K Mahakkanukrauh, A Suwannaroj, S Seerasaporn, P Pongchaiyakul, C |
2022 |
Scientific reports 1 (12), pp. 18198 |
|
| 49. | Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients. | Foocharoen, C Mahakkanukrauh, A Maleewong, P Maleewong, W Jumnainsong, A Pongkulkiat, P Teawtrakul, N Suwannaroj, S Nanagara, R |
2022 |
The American journal of the medical sciences 6 (363), pp. 519-525 |
|
| 50. | Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis. | Pongkulkiat, P Thinkhamrop, B Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 |
BMC rheumatology 1 (6), pp. 33 |
|
| 51. | Skin thickness affects the result of tuberculin skin test in systemic sclerosis. | So-Ngern, A Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2022 |
BMC rheumatology 1 (6), pp. 48 |
|
| 52. | Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis. | Rompsaithong, U Sirithanaphol, W Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 |
Rheumatology (Oxford, England) 10 (61), pp. 4016-4023 |
|
| 53. | Development and validation of machine learning for early mortality in systemic sclerosis. | Foocharoen, C Thinkhamrop, W Chaichaya, N Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B |
2022 |
Scientific reports 1 (12), pp. 17178 |
|
| 54. | Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis. | Thepwiwatjit, S Charoensri, S Sirithanaphol, W Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 |
Journal of scleroderma and related disorders 3 (7), pp. 234-242 |
|
| 55. | Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis. | Laovirojjanakul, W Yospaiboon, Y Anutarapongpan, O Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2022 |
Clinical ophthalmology (Auckland, N.Z.) (16), pp. 3447-3455 |
|
| 56. | Management review of scleroderma renal crisis: An update with practical pointers. | Foocharoen, C Tonsawan, P Pongkulkiat, P Anutrakulchai, S Mahakkanukrauh, A Suwannaroj, S |
2023 |
Modern rheumatology 1 (33), pp. 12-20 |
|
| 57. | Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study. | Sriwong, WT Srisangwarn, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 |
Clinical rheumatology 1 (42), pp. 117-124 |
|
| 58. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health. | Foocharoen, C Ngamjarus, C Pattanittum, P Suwannaroj, S Pongkulkiat, P Onchan, T Wattanasukchai, L Chaiyarit, J Mahakkanukrauh, A |
2023 |
Clinical rheumatology (), pp. 1-8 |
|
| 59. | Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients. | Wantha, O Mahakkanukrauh, A Tuydaung, K Donsrichan, W Yingyaun, K Kaewmeun, S Suwannaroj, S Foocharoen, C |
2023 |
International journal of rheumatic diseases 4 (26), pp. 751-758 |
|
| 60. | Sleep quality and clinical association with sleep disturbance in systemic sclerosis. | Wongthawa, N So-Gnern, A Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 |
BMC rheumatology 1 (7), pp. 21 |
|
| 61. | Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients. | Foocharoen, C Kingkaew, P Teerawattananon, Y Mahakkanukrauh, A Suwannaroj, S Manasirisuk, W Chaiyarit, J Sangchan, A |
2023 |
International journal of rheumatic diseases 10 (26), pp. 2037-2046 |
|
| 62. | Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health. | Foocharoen, T Onchan, T Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 |
Open access rheumatology : research and reviews (15), pp. 213-222 |
|
| 63. | Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study. | Werakiat, J Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2024 |
Rheumatology and immunology research 2 (5), pp. 107-116 |
|
| 64. | The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database. | Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Onchan, T Foocharoen, C |
2024 |
Scientific reports 1 (14), pp. 16981 |
|
| 65. | Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up. | Mahakkanukrauh, A Foocharoen, C Chaosuwannakit, N Suwannaroj, S Pongkulkiat, P Onchan, T Pussadhamma, B |
2024 |
Rheumatology and immunology research 2 (5), pp. 117-125 |
|
| 66. | Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis. | Onchan, T Foocharoen, C Pongkulkiat, P Suwannaroj, S Mahakkanukrauh, A |
2024 |
Scientific reports 1 (14), pp. 20646 |
|
| 67. | Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody. | Suwannamajo, R Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2024 |
Clinical, cosmetic and investigational dermatology (17), pp. 301-309 |
|
| 68. | Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients. | Mulalin, K Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Onchan, T Kasa, S Foocharoen, C |
2024 |
Scientific reports 1 (14), pp. 10354 |
|
| 69. | Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis. | Mahakkanukrauh, A Ngamjarus, C Pattanittum, P Suwannaroj, S Pongkulkiat, P Onchan, T Foocharoen, C |
2025 |
Annals of medicine 1 (57), pp. 2479238 |
|
| 70. | Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review. | Senaveenin, N Mahakkanukrauh, A Foocharoen, C Suwannaroj, S Onchan, T Pongkulkiat, P |
2025 |
Scientific reports 1 (15), pp. 20665 |
|
| 71. | Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire. | Ruangnopparut, R Osiri, M Suwannaroj, S Mahakkanukrauh, A Pongkulkiat, P Onchan, T Foocharoen, C |
2025 |
Clinical rheumatology 8 (44), pp. 3235-3243 |
|
| 72. | Case Report: Chalk-Like Synovial Fluid and Calcified Synovium in Systemic Sclerosis Overlapping With Rheumatoid Arthritis Stabilized by Rituximab. | Khounthep, A Thummaroj, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2025 |
International journal of rheumatic diseases 7 (28), pp. e70352 |
|
| 73. | Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia. | Hongkanjanapong, S Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2025 |
The American journal of the medical sciences 1 (369), pp. 35-43 |
|
| 74. | Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon. | Namvijit, S Foocharoen, C Suwannaroj, S Pongkulkait, P Onchan, T Mahakkanukrauh, A |
2025 |
Rheumatology and immunology research 1 (6), pp. 52-58 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A | JK Jenkins S Suwannaroj KB Elbourne K Ndebele RW McMurray |
2001 |
INTERNATIONAL IMMUNOPHARMACOLOGY 11.0 (1.0), pp. 1897.0-1911.0 |
91 | 0 | 0 | 0 | 0 | 0 | 91 | |
| 2. | Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) | S Suwannaroj A Lagoo D Keisler RW McMurray |
2001 |
LUPUS 4.0 (10.0), pp. 258.0-265.0 |
100 | 0 | 0 | 0 | 0 | 0 | 100 | |
| 3. | Differential effects of sex steroids on T and B cells: Modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels | RW McMurray S Suwannaroj K Ndebele JK Jenkins |
2001 |
PATHOBIOLOGY 1.0 (69.0), pp. 44.0-58.0 |
121 | 0 | 0 | 0 | 0 | 0 | 121 | |
| 4. | Long term treatment outcome of Salmonella septic arthritis. | R Nanagara S Suwannaroj A Mahakkanukrauh HR Schumacher |
2001 |
ARTHRITIS AND RHEUMATISM 9.0 (44.0), pp. S348-S348 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Salmonella group D septic arthritis and necrotizing fasciitis in a patient with rheumatoid arthritis and diabetes mellitus | S Suwannaroj P Mootsikapun K Vipulakorn R Nanagara |
2001 |
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 2.0 (7.0), pp. 83.0-85.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 6. | Suppression of renal disease and mortality in the female NZB x NZW F-1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid | S Suwannaroj A Lagoo RW McMurray |
2001 |
LUPUS 8.0 (10.0), pp. 562.0-567.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 7. | The association of HLA and systemic sclerosis (SSc) in the Northeastern Thais - A preliminary study in 60 patients | S Suwannaroj A Mahakkanukrah C Leelayuwat A Romphruk C Puapairoj R Nanagara |
2001 |
ARTHRITIS AND RHEUMATISM 9.0 (44.0), pp. S179-S179 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 8. | Systemic sclerosis (SSC) in the northeastern Thais: A clinical data in 506 patients | S Suwannaroj A Mahakkanukrauh R Nanagara |
2004 |
ANNALS OF THE RHEUMATIC DISEASES (63.0), pp. 338.0-338.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | CLINICAL FEATURES OF TUBERCULOUS SEPTIC ARTHRITIS IN KHON KAEN, THAILAND A 10-YEAR RETROSPECTIVE STUDY | Chingching Foocharoen Ratanavadee Nanagara Thanit Foocharoen Pirun Mootsikapun Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2010 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 6.0 (41.0), pp. 1438.0-1446.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 10. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand | Chingching Foocharoen Ratanavadee Nanagara Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (14.0), pp. E14-E21 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 11. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand | Chingching Foocharoen Ratanavadee Nanagara Songsak Kiatchoosakun Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (14.0), pp. 282.0-289.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 12. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients | Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2011 |
CLINICAL RHEUMATOLOGY 9.0 (30.0), pp. 1235.0-1240.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 13. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment | Chingching Foocharoen Ratanavadee Nanagara Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 4.0 (14.0), pp. 353.0-360.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 14. | INCIDENCE RATE AND CAUSES OF INFECTION IN THAI SSc PATIENTS | C. Foocharoen Y. Siriphanon A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 |
RHEUMATOLOGY (51.0), pp. 95.0-96.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | Incidence rate and causes of infection in Thai systemic sclerosis patients | Chingching Foocharoen Yada Siriphannon Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (15.0), pp. 277.0-283.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 16. | PATTERN OF SKIN THICKNESS PROGRESSION AND CLINICAL CORRELATION IN THAI SCLERODERMA PATIENTS | C. Foocharoen A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 |
RHEUMATOLOGY (51.0), pp. 94.0-95.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients | Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 5.0 (15.0), pp. E90-E95 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 18. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients | Wichak Kunyakham Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 |
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY 2.0 (30.0), pp. 152.0-157.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 19. | PROGNOSTIC FACTORS OF MORTALITY AND 2-YEAR SURVIVAL ANALYSIS OF SSc WITH PULMONARY ARTERIAL HYPERTENSION IN THAILAND | C. Foocharoen R. Nanagara S. Kiatchoosakun S. Suwannaroj A. Mahakkanukrauh |
2012 |
RHEUMATOLOGY (51.0), pp. 95.0-95.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 20. | SPONTANEOUS SKIN REGRESSION AND PREDICTORS OF SKIN REGRESSION IN THAI SCLERODERMA PATIENTS | C. Foocharoen A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 |
RHEUMATOLOGY (51.0), pp. 93.0-94.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 21. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database | Chingching Foocharoen Yupa Thavornpitak Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 1.0 (16.0), pp. 41.0-46.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 22. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database | Ajanee Mahakkanukrauh Yupa Thavornpitak Chingching Foocharoen Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 4.0 (16.0), pp. 387.0-391.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis | Sittichai Netwijitpan Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
CLINICAL RHEUMATOLOGY 3.0 (32.0), pp. 361.0-367.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 24. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients | Patipat Kitchongcharoenying Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY 4.0 (31.0), pp. 314.0-319.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 25. | ASYMPTOMATIC CARDIAC INVOLVEMENT IN THAI SYSTEMIC SCLEROSIS: PREVALENCE AND CLINICAL CORRELATION | C. Foocharoen B. Pussadhamma A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2014 |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2.0 (32.0), pp. S93-S93 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Incidence of Pulmonary Hypertension in Patients With Systemic Sclerosis and No Pulmonary Symptoms: Is Annual Echocardiographic Screening Necessary? | Chingching Foocharoen Ajanee Mahakkanukrauh Burabha Pussadhamma Sittichai Netwijitpan Siraphop Suwannaroj Ratanavadee Nanagara |
2014 |
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 5.0 (20.0), pp. 268.0-274.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 27. | Prevalence and Causes of Loss to Follow-up Among Patients With Systemic Sclerosis | Chingching Foocharoen Patinut Yenrom Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2014 |
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 8.0 (20.0), pp. 456.0-456.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 28. | Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report) | Chingching Foocharoen Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2015 |
RHEUMATOLOGY 9.0 (54.0), pp. 1616.0-1621.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 29. | Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis | Pichaporn Sumphao-Ngern Chingching Foocharoen Watchara Boonsawat Ajanee Mahakkanukrauh Siraphop Suwannaroj Uraiwan Sae-Oue Sittichai Netwijitpan Ratanavadee Nanagara |
2015 |
ARCHIVES OF MEDICAL SCIENCE 6.0 (11.0), pp. 1255.0-1260.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 30. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma | Chingching Foocharoen Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2016 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 9.0 (19.0), pp. 913.0-923.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 31. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I | Chingching Foocharoen Prangsuporn Suwannachat Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2016 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (19.0), pp. 312.0-320.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 32. | Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma | Patcharawan Suebmee Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Daris Theerakulpisut Ratanavadee Nanagara |
2016 |
AMERICAN JOURNAL OF THE MEDICAL SCIENCES 2.0 (352.0), pp. 166.0-171.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 33. | Self-assessment of skin tightness severity by scleroderma patients | Kittikorn Daungkum Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Bandit Thinkhamrop Ratanavadee Nanagara |
2016 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 10.0 (19.0), pp. 989.0-995.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 34. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Worawit Louthrenoo Nuntana Kasitanon Wanruchada Katchamart Duangkamol Aiewruengsurat Parawee Chevaisrakul Praveena Chiowchanwisawakit Pornchai Dechanuwong Punchong Hanvivadhanakul Ajanee Mahakkanukrauh Siriporn Manavathongchai Chayawee Muangchan Pongthorn Narongroeknawin Veerapong Phumethum Boonjing Siripaitoon Anawat Suesuwan Siraphop Suwannaroj Parichat Uea-Areewongsa Sittichai Ukritchon Paijit Asavatanabodee Ajchara Koolvisoot Ratanavadee Nanagara Kitti Totemchokchyakarn Kanokrut Nuntirooj Tasanee Kitumnuaypong |
2017 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 9.0 (20.0), pp. 1166.0-1184.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 35. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial | Chingching Foocharoen Kitti Chunlertrith Pisaln Mairiang Ajanee Mahakkanukrauh Siraphop Suwannaroj Suwassa Namvijit Orathai Wantha Ratanavadee Nanagara |
2017 |
RHEUMATOLOGY 2.0 (56.0), pp. 214.0-222.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 36. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais | Chingching Foocharoen Piyakarn Watcharenwong Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2017 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 10.0 (20.0), pp. 1572.0-1581.0 |
30 | 0 | 0 | 0 | 0 | 0 | 30 | |
| 37. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis | R. Apipattarakul C. Foocharoen S. Netwijitpan A. Mahakkanukrauh S. Suwannaroj P. Limpawattana R. Nanagara |
2018 |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 4.0 (36.0), pp. S76-S81 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 38. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study | Thapanee Tipparot Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Burabha Pussadhamma Narumol Chaosuwannakit |
2019 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 12.0 (22.0), pp. 2125.0-2133.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 39. | PREVALENCE OF PERIPHERAL EOSINOPHILIA AND CLINICAL ASSOCIATIONS IN THAI SYSTEMIC SCLEROSIS PATIENTS | Chingching Foocharoen Patnarin Kongkulkiat Ajanee Mahakkanukrauh Pewpan Maleewong Intapan Wanchai Maleewong Amonrat Jumnainsong Nattiya Teawtrakul Siraphop Suwannaroj Ratanavadee Nanagara |
2019 |
ANNALS OF THE RHEUMATIC DISEASES (78.0), pp. 1226.0-1227.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 40. | TUBERCULIN SKIN TEST FOR DETECTION OF TUBERCULOSIS IN SYSTEMIC SCLEROSIS | Apichat So-Ngern Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2019 |
ANNALS OF THE RHEUMATIC DISEASES (78.0), pp. 855.0-856.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 41. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study | Chingching Foocharoen Udomlack Peansukwech Ajanee Mahakkanukrauh Siraphop Suwannaroj Patnarin Pongkulkiat Penpiriya Khamphiw Ratanavadee Nanagara |
2020 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 7.0 (23.0), pp. 945.0-957.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 42. | Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study | Burabha Pussadhamma Thapanee Tipparot Naruemol Chaosuwannakit Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2020 |
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2020.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 43. | Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database | Chingching Foocharoen Udomlack Peansukwech Patnarin Pongkulkiat Ajanee Mahakkanukrauh Siraphop Suwannaroj |
2020 |
MODERN RHEUMATOLOGY 6.0 (30.0), pp. 1025.0-1032.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 44. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study | Chingching Foocharoen Kitti Chunlertrith Pisaln Mairiang Ajanee Mahakkanukrauh Siraphop Suwannaroj Suwassa Namvijit Orathai Wantha Ratanavadee Nanagara |
2020 |
SCIENTIFIC REPORTS 1.0 (10.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 45. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database | Chingching Foocharoen Udomlack Peansukwech Patnarin Pongkulkiat Ajanee Mahakkanukrauh Siraphop Suwannaroj |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 46. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis | Thanachit Krikeerati Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 |
MODERN RHEUMATOLOGY 3.0 (31.0), pp. 649.0-656.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 47. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study) | Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 |
AMERICAN JOURNAL OF THE MEDICAL SCIENCES 6.0 (362.0), pp. 570.0-577.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 48. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease | Itthiphat Arunsurat Ajanee Mahakkanukrauh Chingching Foocharoen Siraphop Suwannaroj Ratanavadee Nanagara |
2021 |
CLINICAL RHEUMATOLOGY 1.0 (40.0), pp. 205.0-211.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 49. | Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis | Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 |
ARCHIVES OF MEDICAL SCIENCE 6.0 (17.0), pp. 1696.0-1705.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 50. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis | Arporn Jutiviboonsuk Lingling Salang Nuntasiri Eamudomkarn Ajanee Mahakkanukrauh Siraphop Suwannaroj Chingching Foocharoen |
2021 |
CLINICAL RHEUMATOLOGY 6.0 (40.0), pp. 2267.0-2275.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 51. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis | Wiriya Chuealee Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Chatlert Pongchaiyakul Ratanavadee Nanagara |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 52. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients | Yathao Paolee Chingching Foocharoen Suranut Charoensri Mayfong Mayxay Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Treatment of Gout in General Practice | Siraphop Suwannaroj Ratanavadee Nanagara |
1998 |
Srinagarind Medical Journal (13 No 4), pp. 224-228 |
|
| 2. | Intravenous Immunolobulin (IV Ig) Treatment of Demyelinating Polyneuropathy in Patient with Systemic Lupus Erythematosus (SLE) : A Case Report and Review of the Literatures. | Siraphop Suwannaroj Ratanavadee Nanagara Valee Harisdandkul |
1998 |
Srinagarind Medical Journal (13 No 2), pp. 107-111 |
|
| 3. | Interesting case anaphylaxis after intra-articular steroid injection in out patient department : review literature | Chingching Foocharoen Siraphop Suwannaroj |
2004 |
Srinagarind Medical Journal (19 No 2), pp. 103-107 |
|
| 4. | Development of Quality Indicators of Dispensing Process for Hospital Pharmacists in Rheumatoid Arthritis Patients | Ratchanok Boondee Pattarin Kittiboonyakun Siraphop Suwannaroj Phayom Sookaneknun |
2012 |
Isan Journal of Pharmaceutical Sciences (8 No 3), pp. 76-90 |
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|